Current News

H1N1 Influenza A Virus Information

HDMA Elevates Bittman to Chief Operating Officer, Introduces Naylor as Vice President for Meetings

Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs

Center for Healthcare Supply Chain Research Issues New Publication Featuring Specialty Pharmaceutical Segment

DIANA, Nexus and Power of Partnership Awards Presented at 2009 Annual Leadership Forum

Distributors Work with States to Take On Flu Pandemic Challenge


Visit HDMA News Center >


print page

 


 

 

Contact:
Jeff Van Ness, HDMA, (703) 885-0216
jvanness@hdmanet.org

HDMA CALLS FOR CONTINUED EMPHASIS ON PATIENT SAFETY AND INTEGRITY OF THE U.S. PHARMACEUTICAL SUPPLY CHAIN, IN RESPONSE TO RELEASE OF
HHS DRUG IMPORTATION TASK FORCE REPORT

RESTON, Va., Dec. 21, 2004 –– The Healthcare Distribution Management Association (HDMA), representing full-service U.S. healthcare distributors, stated today it is fully reviewing the Health and Human Services (HHS) Task Force Report on Importation. “The nation’s healthcare distributors are committed, first and foremost to patient safety and the integrity of the U.S. pharmaceutical supply chain. As such, we are continuing our work with the Administration and Congress to ensure that a safe and secure prescription drug supply chain is the paramount consideration in the debate over drug importation,” said John M. Gray, HDMA President and CEO.

“HDMA and our member company distributors have testified before the HHS Task Force and we’ve been consistently outspoken on the critical importance of assuring patient safety when considering the issues of drug importation. Our focus has been, and continues to be, on three key safety issues we believe must be thoroughly addressed: product authentication, product integrity, and product availability. Each offers significant challenges that require extensive study and consideration before moving forward with any importation proposal.”

Gray continued, “Today as drug counterfeiting and terrorism are front-and-center issues, we urge policymakers to be exceedingly careful before moving forward with any program to import medicines from abroad. HDMA will continue to provide policymakers with fact-based information on supply chain issues as importation is considered.
In the meantime, we applaud the continued efforts of HHS to conduct a comprehensive review of the issues and identification of the concerns surrounding importation.”


About HDMA
The Healthcare Distribution Management Association (HDMA) is the national association representing primary, full-service healthcare distributors. Each business day, the member companies of HDMA are responsible for ensuring that more than eight million prescription medicines and healthcare products are safely delivered to 145,000 pharmacies, hospitals, nursing homes, physician offices, clinics, government and other providers in all 50 states. This essential public health function is provided with tremendous efficiency, saving the nation’s healthcare system nearly $32 billion each year. HDMA and its members are the vital link in the healthcare system, working daily to provide value, remove costs and develop innovative solutions to deliver care safely and effectively.


 
© Copyright Healthcare Distribution Management Association.
All rights reserved.
HDMA: M | C | D
Do you have suggestions
for our site?
URL: